GILD vs NVS
Gilead Sciences vs Novartis AG — AI-powered side-by-side comparison
| Metric | GILD | NVS |
|---|---|---|
| AI Score | 63 | 71 |
| Price | $131.77 | $154.44 |
| P/E Ratio | -50.68× | 23.58× |
| ROE | 37.5% | 30.5% |
| Revenue Growth YoY | — | — |
| Gross Margin | 79.6% | 74.3% |
| Debt / Equity | 0.00× | 1.18× |
| Dividend Yield | 2.4% | 2.9% |
| RSI (14) | 49.6 | 46.9 |
| Beta | 0.343 | 0.46 |
| Expected Upside | +19.4% | +1.2% |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
GILD Full Analysis
NVS Full Analysis